OpGen > Investor Relations > Overview


Corporate Profile

OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. The company’s products and services are designed to enable the rapid identification of hospital patients who are colonized or infected with life-threatening, multi-drug resistant organisms, MDROs.

Upcoming Events

There are currently no events scheduled.

More Events

OPGN (Common Stock)
Exchange :NASDAQ CM (US Dollar)
Price :$1.18
Change : Stock is Up 0.02 (0.85%)
Volume :237,690
Data as of 01/20/17 4:00 p.m. ET
Minimum 20 minute delay
Data Provided by Thomson Reuters